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Introduction

Hematopoietic Stem Cell Transplantation (HSCT)
is a therapy used for treatment of two conditions, one comprising non-malignant diseases resulting from bone marrow function failure or cells derived from bone marrow, in which transplant is used to replace a defective tissue, and in another condition, most prevalent, used for neoplastic diseases, particularly malignant (1) (2) . The term HSCT is used to replace Bone Marrow Transplantation (BMT), since it describes the current form of the procedure, which involves Hematopoietic Stem Cells (HSC) directly aspirated from bone marrow, peripheral stem cells mobilized from the marrow compartment into the peripheral blood, or from the umbilical cord blood (3) (4) .
There are two main types of transplant: autologous, when the patient is his own donor and allogeneic, when someone is compatible as a donor, which may be a family member, a volunteer, or cells from stored umbilical cord blood. Rarely, patients may have an identical twin, allowing the syngeneic transplant. For all types of HSCT, a tunneled Central Venous Catheter (CVC) is usually placed for the administration of chemotherapy, stem cell infusion, intravenous medication, electrolyte supplements, nutritional support and blood products (1) . Some procedures are essential after insertion of Central Venous Catheter, because, if there is loss of permeability of the pathways and it is not treated quickly, there will be a permanent loss of access. In addition, there will also be increased morbidity resulting from new catheterizations, thereby raising the risk of infection due to the formation of fibrin and adherence of bacteria and fungi, worsened by the large number of catheter manipulations, amount of lumens, type of clothing and age of the patient (5) .
The granulocytopenia secondary to the conditioning chemotherapy determines the risk of catheter-related infections, which may serve as an entry into the blood circulation, leading to bacteremia, fungemia, and consequently to septic shock and death. The risks of infection and the spectrum of infectious syndromes differ according to the type of transplant, conditioning regimen, type of implant of stem cells and therapies used after the procedure (1, 6) . In HSCT units, there are situations that culminate in the early removal of the catheter, resulting in rework that, in addition to increasing the chance of complications, directly reflects on the cost and course of treatment, and still causes great distress to patients and their families and/or caregivers. Therefore, it is important to research the causes of removal of central venous access in patients during HSCT process, as well as which factors influence these causes, so that staff can develop a safer care. (7) .
Results
Of the 188 patients, 58% (110) were male. The identified complications were fever/ bacteremia 13.65% A higher prevalence of staying with the catheter until hospital discharge was observed among females, which showed correspondence association with tunelitis/ hyperemia, followed by loss of access due to accidental removal. Fever/bacteremia, obstruction, exteriorization www.eerp.usp.br/rlae Barretta LM, Beccaria LM, Cesarino CB, Pinto MH.
of catheter fixation cuff (Hickman) and subcutaneous extravasation were more significant among males, with a greater number of deaths. The association between infection and gender was not statistically significant.
Hickman catheter was the most commonly used, with 70% (175), followed by Double Lumen (DL) catheter 7x20cm with 16% (40), hemodialysis catheter (SHILLEY R ) with 11% (27) and others with low incidence of implantation, 3% (7) . Hickman catheter showed a higher association with obstruction, infection, tunelitis/ hyperemia, in addition to the exteriorization of catheter fixation cuff, which is its characteristic. DL catheter was associated with extravasation and the most commonly used in patients who died after transplant, whereas hemodialysis catheter was associated with fever/ bacteremia and Permicath R catheter, 0.01% (3), did not present complications.
In allogeneic HSCT, 21.80% (41), there was a higher incidence of subcutaneous extravasation and tunelitis/hyperemia, whereas in autologous, 78.19% tests, reducing costs and complication rates (6, (8) (9) (10) .
Complications related to CVC appear immediately, or late, associated with the introduction, permanence and its use. Infection, thrombotic obstruction, exteriorization of catheter fixation cuff, accidental removal, peri-insertion tunelitis/hyperemia, leakage and arrhythmia were identified in 47% of patients with inserted catheters, which corroborates recent studies that show a range of variation from 8 to 69% in the rates of complications related to catheter (11) (12) (13) .
Infection and obstruction are the most common occurrences and can be caused by multiple factors such as the type of cancer, chemotherapy protocol, caliber of the catheter, insertion site, surgical technique, prior mediastinal irradiation and improper handling by the staff. The age of the patient also exhibited high association with this complication, because the younger the patient, the greater the incidence of infections (6, (14) (15) (16) .
Some bacterial infections that occur after autologous due to intravenous nutritional supplementation (1) .
Children (under the age of 10 years) showed association with fever/bacteremia and infection, reported in 5.22% of implanted catheters, representing 10% of the identified complications. To set infection related to catheter, it was considered the variation of this data, since 13% of infection were treated as fever/bacteremia resulting from unknown causes.
The incidence of catheter-related infections ranges from 9 to 80%, depending on the model and patient risk factors, as well as its setting. There are those who consider, for a definitive diagnosis, the need to observe the growth of the same microorganism at least in a sample from peripheral blood and from the catheter tip.
However there are those who also evaluate the clinical symptomatology (13, (14) (15) (16) (17) (18) .
Long-term CVC is also more prone to poor positioning of the distal tip, kinking and thrombosis,
with an incidence of 8-20% in patients undergoing autologous stem cell transplantation and lower incidence in the allogeneic and syngeneic (19) . Cancer patients are at increased risk of thromboembolism and often develop blood clots in the catheter, which besides causing obstruction, favors the incidence of infections and represents 3 to 38.3% of complications in adult patients (6, 14, 18) .
Regarding the insertion site, there were no which the use of the catheter is required (20) (21) .
In a study of 100 children after HSCT, it was observed that 80 had their catheters successfully implanted in the right or left external jugular, with dissection, which made the technique simple and safe. In this case, the preferred site for CVC implantation was the subclavian vein (76%), which associated to Hickman, provides more comfort to patients who stay for long periods with catheters, alternating between hospitalizations for chemotherapy and home recovery (22) .
Regarding the length of stay with the catheter, (16, (23) (24) .
Regarding the type of HSCT, complications showed a greater association with the autologous type, although the conditioning method used does not cause immunoablation as in allogeneic transplants that, together, produce hematopoietic pancytopenia and immunocytopenia, favoring the occurrence of opportunistic infections such as those related to CVC (25) .
The occurrence of CVC complications, in relation to the type of transplant, were related to medical diagnosis, since the chemotherapy agents used in most allogeneic conditioning regimens cause dermatitis, rash and skin fragility because they are dermatologically toxic, which can compromise the healing in the insertion site and favor infection. The type of disease, the conditioning regimen and the prior mediastinal irradiation are considered predisposing factors for CVC complications, particularly infection, which was observed in patients with AML and NHL (13, 15, 25) .
By choosing CVC, some factors must be considered, such as purpose, expected treatment duration, type of conditioning, training of the team that will handle the device, age of the patient and education level of the caregiver, since most of the time, infections related to CVC can be minimized and/or avoided (23) (24) . 
Conclusion
